Europe
In addition to the planned BioNTech IPO, many other pharma and biotech companies in Europe, Asia and elsewhere shared news for the week.
The goal is to improve the yield and quality of next-generation gene therapy vectors—typically viruses—using artificial intelligence (AI) and machine learning.
For BioNTech, the IPO will follow a funding round that brought about $270 million into the coffers of the privately-held company.
Planmeca is introducing a new chairside 3D printer to its product offering.
Planmeca is pleased to introduce Planmeca Romexis® Dental PACS, the first software platform to allow image archiving, viewing and treatment planning in a single software.
Planmeca is proud to announce a renewed version of its groundbreaking all-in-one software, Planmeca Romexis®.
Planmeca has introduced a new member to its growing Planmeca Viso™ product family of next generation imaging units.
Planmeca is proud to introduce the world’s first dental unit integrated water treatment system that uses electro-chemical activation technology.
In order to manage a large dental clinic or a clinic chain as effectively as possible, a lot of data and the right tools to access and analyse that data are needed.
Planmeca is introducing a new operating light with two fully integrated 4K cameras, stereo microphones and computerised image processing technology.
PRESS RELEASES